Apg Asset Management Us Inc. Gilead Sciences, Inc. Transaction History
Apg Asset Management Us Inc.
- $14.6 Billion
- Q3 2024
A detailed history of Apg Asset Management Us Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Apg Asset Management Us Inc. holds 28,965 shares of GILD stock, worth $2.56 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
28,965
Previous 369,126
92.15%
Holding current value
$2.56 Million
Previous $25.3 Million
90.42%
% of portfolio
0.02%
Previous 0.15%
Shares
4 transactions
Others Institutions Holding GILD
# of Institutions
1,926Shares Held
994MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$10.7 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.2 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$6.77 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.46 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.32 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $111B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...